The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA
The future of public health in an “RNA world” is on trial in a trade secrecy dispute worth $950 million.
Trade Secrets
-
Read more: The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA -
Read more: Reclaiming Global Public Health Reclaiming Global Public Health
The promise of COVID vaccines has been unevenly realized: fault lines have emerged between those able to secure doses and those left behind.
-
Read more: COVID ‘Compromise’ on International IP Underscores Need for New Approach COVID ‘Compromise’ on International IP Underscores Need for New Approach
For COVID treatments and diagnostics to be broadly available at affordable prices, their IP must be considered a global public good.
-
Read more: The Risk of Pervasive Trade Secret Practices Within the Life Sciences The Risk of Pervasive Trade Secret Practices Within the Life Sciences
Trade secrets offer a number of benefits for life sciences companies compared to patents, such as theoretical indefinite intellectual property protection.
-
Read more: Decolonizing the Pandemic Treaty Through Vaccine Equity Decolonizing the Pandemic Treaty Through Vaccine Equity
Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.
-
Read more: The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good
The pandemic has laid bare the lack of regulation for the sharing of intellectual property needed for an effective and equitable response.
-
Read more: Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic
Activists in the access-to-medicines movement have mobilized to combat the threat of vaccine/therapeutic apartheid during the COVID-19 pandemic.
-
Read more: The Prospects for an IP Waiver Under the TRIPS Agreement The Prospects for an IP Waiver Under the TRIPS Agreement
Going forward, practical solutions should focus on scaling up manufacturing and supply, and improving access and affordability.
-
Read more: US Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean? US Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean?
An explanation of the WTO waiver of COVID-19 intellectual property, what the U.S. declaration of support means, and likely effects of the waiver.
-
Read more: Innovation and the Firm: Vertical Integration in Patent-Intensive Industries – Seminar 9/8 at the University of Copenhagen Innovation and the Firm: Vertical Integration in Patent-Intensive Industries – Seminar 9/8 at the University of Copenhagen
Looking forward to hear Professor Peter Lee’s (UC Davis) talk on “Innovation and the Firm: Vertical Integration in Patent-Intensive Industries” at the University of Copenhagen on Friday, Friday, September 8th 2017 from 10:00 – 12:00. If you are interested to join, please register here. Abstract of Professor Lee’s talk: Recent scholarship has highlighted the prevalence of…